Literature DB >> 8916628

Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics.

S Shiffman1, M Hickcox, J A Paty, M Gnys, J D Kassel, T J Richards.   

Abstract

Determinants of progression from an initial smoking lapse to relapse, using prospective data from 133 participants were examined. Participants used palm-top computers to record their first lapse, and their reaction to it, within minutes of the event, and were followed for 3 months to assess subsequent smoking. Indicators of the Abstinence Violation Effect--self-efficacy, attributions, and affective reactions to the lapse--generally failed to predict progression to relapse, but participants who felt like giving up after the first lapse progressed more rapidly to a second lapse. Participants who attempted restorative coping were less likely to progress to another lapse on the same day. Those whose lapses were triggered by stress progressed more quickly, whereas those triggered by eating and drinking or accompanied by alcohol consumption progressed more slowly. More nicotine-dependent participants progressed more rapidly toward relapse, but neither the amount smoked in the first lapse nor its subjective reinforcement predicted progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916628     DOI: 10.1037//0022-006x.64.5.993

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  89 in total

1.  Ecological momentary analysis of the relations among stressful events, affective reactivity, and smoking among smokers with high versus low depressive symptoms during a quit attempt.

Authors:  Haruka Minami; Brandon E Frank; Krysten W Bold; Danielle E McCarthy
Journal:  Addiction       Date:  2017-10-12       Impact factor: 6.526

2.  Blunted vagal reactivity predicts stress-precipitated tobacco smoking.

Authors:  Rebecca L Ashare; Rajita Sinha; Rachel Lampert; Andrea H Weinberger; George M Anderson; Meaghan E Lavery; Katherine Yanagisawa; Sherry A McKee
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

3.  Smoking initiation among nonsmokers during and following treatment for alcohol use disorders.

Authors:  Karen B Friend; Maria E Pagano
Journal:  J Subst Abuse Treat       Date:  2004-04

Review 4.  Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions.

Authors:  Judson A Brewer; Hani M Elwafi; Jake H Davis
Journal:  Psychol Addict Behav       Date:  2012-05-28

5.  Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse.

Authors:  Mustafa al'Absi; Dorothy Hatsukami; Gary L Davis
Journal:  Psychopharmacology (Berl)       Date:  2005-04-15       Impact factor: 4.530

6.  Individual and combined effects of multiple high-risk triggers on postcessation smoking urge and lapse.

Authors:  Cho Y Lam; Michael S Businelle; Carrie J Aigner; Jennifer B McClure; Ludmila Cofta-Woerpel; Paul M Cinciripini; David W Wetter
Journal:  Nicotine Tob Res       Date:  2013-12-09       Impact factor: 4.244

Review 7.  A contextual model of self-regulation change mechanisms among individuals with addictive disorders.

Authors:  Corey R Roos; Katie Witkiewitz
Journal:  Clin Psychol Rev       Date:  2017-08-24

8.  Do resisted temptations during smoking cessation deplete or augment self-control resources?

Authors:  Kathleen A O'Connell; Joseph E Schwartz; Saul Shiffman
Journal:  Psychol Addict Behav       Date:  2008-12

9.  Sex differences in hormonal responses to stress and smoking relapse: a prospective examination.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Sharon Allen; Andrine Lemieux; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

10.  TIME-VARYING COEFFICIENT MODELS FOR JOINT MODELING BINARY AND CONTINUOUS OUTCOMES IN LONGITUDINAL DATA.

Authors:  Esra Kürüm; Runze Li; Saul Shiffman; Weixin Yao
Journal:  Stat Sin       Date:  2016-07       Impact factor: 1.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.